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P.PORTO Research Workshops are thematic meetings, to present and discuss R&D activities and outcomes 
– be it in the form of new knowledge, applied technology, industrial or intellectual property – providing a 
space for debate, networking and creation of synergies. 
This volume provides the contributions of the Research Workshop of April 2019, dedicated to the set of 
R&D projects led by P.PORTO researchers, in collaboration with companies and end-users, in the scope of 
the national projects call 02/SAICT/2016. 
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Novel natural and synthetic compounds for treating 
hormone resistant tumors 
Regina Silva, PhD * 
Research Center in Health and Environment, School of Health,  
Polytechnic Institute of Porto, Portugal 
 
Abstract  
Cancer is a leading cause of mortality worldwide. Despite significant advances in medical 
research, deaths due to cancer are continuously increase. Data from 2010 has shown the colorectal, 
breast, prostate and lung cancer as the most common in Portugal. Considering the North Region, 
prostate cancer and breast cancer are the most incident in men and women, respectively. Despite 
all the improvement in cancer early detection and treatment, the high mortality rates challenges 
the discovery of new anticancer agents. In the last years, several team members were involved in 
the study of the bioactive potential of natural and synthetic compounds at the Health and 
Environment Research Centre at School of Health of the Polytechnic Institute of Porto (CISA-
ESS—P.Porto). From previous works, extracts isolated from plants and synthetic compounds, such 
as ionic liquids and quinoxalines, revealed an interesting bioactive potential as cancer drug. 
Following these previous approaches and considering the background of the team members in 
cancer research, the main goal of this project is to infer about the potential of these natural and 
synthetic compounds as anti-cancer drugs to common North Portugal cancer hormone-resistant 
tumors, namely castration-resistant prostate tumors and estrogen-independent breast tumors. To 
achieve such goal, the project has a multidisciplinary team with knowhow in natural compounds 
extraction, synthetic chemistry, cell culture, molecular biology, and oncobiology, that will carry 
out the following strategies: a) production and characterization of natural and synthetic compounds 
to be tested for anticancer potential by CISA members with experience in natural compounds 
extraction and compounds synthesis; b) in vitro assessment of the anticancer potential in prostate 
and breast cell lines in order to select the most promising compounds by CISA members with an 
extensive experience in cell cultures and cytotoxicity screening; c) in vivo assessment of the 
* Corresponding author, E-mail: ras@ess.ipp.pt 
 
 
P.PORTO Research Workshops  Workshop on R&D Projects 2016 
2 
anticancer potential of the selected compounds using zebrafish as model. This activity includes a 
collaboration with consultants with a strong expertise in zebrafish model; d) identification of 
altered gene expression upon treatment with the selected compounds in order to infer about the 
molecular mechanism of action underlying their cytotoxic effects on tumor cells; e) ascertain of 
clinical usefulness of altered gene expression on human which might be used to predict therapeutic 
response and thus serve as biomarkers for clinical management and therapeutical guidance. For 
these two last activities, the project has Portuguese Oncology Institute (IPO-Porto) as a partner, 
due to the strong expertise in cancer, namely in PCa and BCa. With this approach, we expect to 
identify new anti-tumor compounds targeting the most common and incident tumors in the North 
Region of Portugal. 
Principal Investigator:  Regina Augusta Silva, CISA|ESS|P.Porto 
Investigators: Agostinho Cruz (CISA|ESS|P.PORTO), Ana Filipa Vieira (CI-IPOP; 
CISA|ESS|P.PORTO), Ana Isabel Oliveira (CISA|ESS|P.PORTO), Carmen Jerónimo (CI-IPOP), 
Cláudia Pinho (CISA|ESS|P.PORTO), Cristina Prudêncio (CISA|ESS|P.PORTO), Mónica Vieira 
(CISA|ESS|P.PORTO), Inês Graça (CI-IPOP), Isa Carneiro (SAP-IPOP), Piedade Barros 
(CISA|ESS|P.PORTO), Ricardo Ferraz (CISA|ESS|P.PORTO), Rosário Martins 
(CISA|ESS|P.PORTO), Rui Henrique (SAP-IPOP)  
Promoting Institution: Research Center in Health and Environment, School of Health, Polytechnic 
Institute of Porto (CISA|ESS|P.PORTO), Portugal  
Copromoting Institution: Cancer Biology and Epigenetics Group – Research Center, Portuguese 
Oncology Institute of Porto (CI-IPOP), Portugal  
Keywords 
Breast cancer, Prostate cancer, Ionic liquids, Quinoxalines, Taraxacum hispanicum 
 
Acknowledgement: NORTE-01-0145-FEDER-024156, supported by Norte Portugal Regional 
Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, 
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Evaluating the effect of the Ionic liquid [C16Pyr] [Amp] in 
hormone-resistant tumors using an in vivo zebrafish assay 
Piedade Barros1 *, Rosário Martins1,2 Agostinho Cruz1 and Regina Silva1 
1 Centro de Investigação em Saúde e Ambiente, Escola Superior de Saúde,  
Instituto Politécnico do Porto, Porto, Portugal 
2 Interdisciplinary Center of Marine and Environmental Research (CIIMAR/CIMAR),  
University of Porto 
 
Abstract  
The NASYTHOR project, aimes to study the potential of novel natural and synthetic compounds 
as anti-cancer drugs on hormone-resistant tumors. One of the objectives is the evaluation of the in 
vivo efficacy of the anticancer activity of the compounds using Danio rerio, zebrafish embryo as 
a model. In this work we describe the general methodology, advantages and disadvantages. Among 
a large range of advantages in the use of zebrafish in cancer research, the high level of genetic and 
physiologic homology with humans, including brain, digestive tract, musculature and vasculature 
can be highlighted. Also, the immature immune system of the embryos favors xenotransplantation 
of human cancer cells, and makes these animals a promising experimental model to tumorigenesis, 
angiogenesis, invasion and metastasis. The ionic liquid cetylpyridinium ampicillin [C16Pyr] 
[Amp] induces cytotoxicity in hormone-resistant breast and prostate cancer cell lines. To study the 
possible use of [C16Pyr] [Amp] as an anticancer, the toxicity towards zebrafish embryos should 
be evaluated first by an acute toxic assay that should be carried out following the OECD 236 
Guideline. The test should include increasing concentrations of [C16Pyr] [Amp], selected within 
those required for an antitumor effect, that should be determined previously. A control treatment 
and a treatment with K2Cr2O7 as a positive control should also be used. Following the acute assay 
with the fish embryos, and considering the toxicity results obtained, studies should proceed to 
evaluate the potential inhibitory effect of the [C16Pyr] [Amp] on breast and prostate cells injected 
in the perivitellin space of zebrafish. Culture prostate and breast line cells, selected for their 
sensitivity to [C16Pyr] [Amp] should be harvested and prepared for microinjection. Zebrafish 
fertilized eggs should be incubated for 48-72h in fish water, collected and dechorionated. 
* Corresponding author, E-mail: pbarros@ess.ipp.pt 
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Anesthetized embryos should be injected with the same cell number. After confirmation of the 
microinjection success, embryos will be transferred and incubated in [C16Pyr] [Amp] treatments 
prepared with fish water and previous selected [C16Pyr] [Amp] anti-tumor effective 
concentrations. With this work we intend to contribute to the development of cancer research, 
increasing the knowledge of the process of prostate and breast hormone-resistant tumor cells 
development in the living zebrafish embryo model. 
 
Keywords 
Ionic liquids, hormone resistant tumors, zebrafish model 
 
Acknowledgements. This research is a result of the project NORTE-01-0145-FEDER-024156, 
supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the 
PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund 
(ERDF) and by the Foundation for Science and Technology (FCT). 
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Natural and synthetic compounds as anti-cancer therapies 
for breast and prostate cancer  
Ângela Marques-Magalhães1,2 §, Filipa Quintela Vieira 1,2 §, Ricardo Ferraz 1,3, Cláudia Pinho 1, 
Mónica Vieira1,4, Ana Isabel Oliveira1, Cristina Prudêncio 1,4, Agostinho Cruz1,  
Carmen Jerónimo 2,5 #, Regina Augusta Silva1 # * 
1Research Center in Health and Environment, School Health of Polytechnic Institute of Porto, Portugal  
2Cancer Biology and Epigenetics Group – Research Center, Portuguese Oncology Institute of Porto, Portugal  
3LAQV-REQUIMTE, Department of Chemistry and Biochemistry, Faculty of Sciences of the University of Porto, Portugal 
4Institute of Health Innovation and Research (I3S), University of Porto, Portugal 
5Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto, 
Portugal 
 
Abstract  
Breast Cancer (BCa) and Prostate Cancer (PCa) are the most prevalent tumors in females and 
males, respectively, being the main causes of cancer morbidity and mortality, worldwide. 
Currently, there is no available curative treatment for the hormone-resistant tumors, being the 
development of new therapeutic strategies using innovative anticancer agents imperative. Thus, 
the main goal of this work was to evaluate the anticancer properties of natural and synthetic 
compounds through in vitro assays.  
BCa, PCa and non-tumor cell lines were treated with natural compounds, extracts of Taraxacum 
hispanicum, and synthetic compounds, ionic liquids and quinoxalines. Phenotypic assays were 
performed for evaluation of cell viability, cytotoxicity, apoptosis and colony formation. Only the 
ionic liquid ([C16Pyr][Amp]) and the alcoholic extract of Taraxacum hispanicum (EAL) are 
associated with significant decreased cell viability, with a high index of selectivity. Hence, the 
additional functional assays were performed only for these two compounds. When characterizing 
the mechanism of cell death, treatments with both compounds proved to sensitize cancer cells to 
apoptosis, while rarely induced cell death by necrosis. Moreover, the ability of colony formation 
was reduced in cell treated with both compounds, although a more pronounced effect has been 
observed in PCa cell lines.   
§ These authors have contributed equally to this work 
# These authors share senior authorship 
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Overall, functional assays revealed that both [C16Pyr][Amp] and EAL have a significative 
antitumor activity. Nevertheless, these observations must be molecularly analyzed to allow the 
identification of the major cellular pathways affected by these compounds.  
 
Keywords 
Breast cancer, Prostate cancer, Natural compounds, Synthetic compounds 
 
Acknowledgements. This research is a result of the project NORTE-01-0145-FEDER-024156, 
supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the 
PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund 
(ERDF) and by the Foundation for Science and Technology (FCT). 
 
 
 
 
P.PORTO Research Workshops  Workshop on R&D Projects 2016 
7 
Molecular impact of [C16Pyr][Amp] treatment on breast 
and prostate cancer cell lines 
Filipa Quintela Vieira1,2 §, Ângela Marques-Magalhães 1,2§, Vera Miranda-Gonçalves2, Ricardo 
Ferraz 1,3, Cristina Prudêncio1,4, Carmen Jerónimo2,3 #, Regina Augusta Silva1 # * 
1Research Center in Health and Environment, School of Health of the Polytechnic Institute of Porto, Portugal  
2Cancer Biology and Epigenetics Group – Research Center, Portuguese Oncology Institute of Porto, Portugal  
3LAQV-REQUIMTE, Department of Chemistry and Biochemistry, Faculty of Sciences of the University of Porto, Portugal 
4Institute of Health Innovation and Research (I3S), University of Porto, Portugal 
5Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar,  
University of Porto, Portugal 
 
Abstract   
Prostate Cancer (PCa) and Breast Cancer (BCa) are the leading causes of cancer morbidity and 
mortality, worldwide, when diagnosed in advanced stages of the disease. Currently available 
therapies have limited curative effect, leading to the progression to highly aggressive hormone-
resistant phenotypes. Thus, the development of new anti-tumor agents becomes imperative. Ionic 
liquids are organic salts with anti-neoplastic activity and have been studied in the pharmaceutical 
industry. Previous work of our team demonstrated that the ionic liquid [C16Pyr][Amp] has 
significant anti-tumor properties in PCa and BCa cell lines. However, the main cellular pathways 
affected were not characterized. Therefore, the aim of this work was to explore the molecular 
impact of [C16Pyr][Amp] treatment in order to identify relevant genes that have altered expression 
upon treatment and that can justify the anti-cancer effect observed in the in vitro assays. 
The treatment effect was evaluated by using a custom expression array panel including several 
genes involved in cell cycle, apoptosis, DNA repair and mTOR or MAPK/ERK pathways. The 
comparative Ct method was used to calculate fold-difference in gene expression between cell line 
with and without treatment and genes with a fold change above 1 or below -1 were considered. 
We were able to identify a panel of differentially expressed genes upon treatment with 
[C16Pyr][Amp] that will be subsequently explored by proteomic studies in human PCa and BCa 
tissues.  
§ These authors have contributed equally to this work 
# These authors share senior authorship 
* Corresponding author, E-mail: ras@ess.ipp.pt 
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Keywords 
Breast cancer, Prostate cancer, Synthetic compounds, Molecular analysis 
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supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the 
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Production and characterization of natural and synthetic 
compounds for treating hormone resistant tumors 
Ana Isabel Oliveira1 , Cláudia Pinho1, Mónica Vieira1,3, Ricardo Ferraz1,2,  
Agostinho Cruz1, Cristina Prudêncio1,3 * 
1Centro de Investigação em Saúde e Ambiente, Escola Superior de Saúde, Instituto Politécnico do Porto, Porto, Portugal 
2 LAQV-REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Porto, Portugal 
3 i3S, Instituto de Investigação e Inovação o em Saúde, Universidade do Porto, Porto 4200-393, Portugal  
 
Abstract  
From previous and on-going studies, natural compounds/extracts isolated from Taraxacum 
hispanicum (1), Ionic Liquids (ILs) based on ampicillin and quinoxalines emerged as potential 
anticancer. Although described as potentially antitumor compounds, the mechanisms undergoing 
cytotoxicity remain unknown. Therefore, production of these kind of compounds were carry out 
in order to have a better understanding of their bioactivity. 
Several approaches were made according to the type of extracts/compounds that were studied. In 
the case of the Ionic Liquids Based on ampicillin (2), the buffer neutralization method was the 
methodology that we used to synthetize and that wasdeveloped and already described by us (2). 
The purity of the compounds was determined by 1H and 13C Nuclear Magnetic Ressonance and 
mass spectrometry. Regarding quinoxalines, the compounds were purified by reduced pressure 
sublimation, and thermal stability was verified by DSC (3). On the topic of the natural compounds, 
the leaves of Taraxacum  hispanicum were collected from a producer in Vila Nova de Gaia 
(Portugal), and authenticated by a specialist. A characterization of the extracts was performed by 
High Pressure Liquid Chromatography (HPLC) and Diode Array (DAD), according to Schütz et 
al (4).  
As expected the products were obtained pure, with good yields and in enough quantity to carry out 
the functional studies with cancer cell lines. 
  
* Corresponding author, E-mail: cprudencio@ess.ipp.pt 
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Novel biosensors for venous thromboembolism in oncology: 
the STRIP2SENSE project 
Carla F. Pereira*, Sara Resende*, Manuela F. Frasco*, M. Goreti F. Sales 
BioMark-CEB/ISEP, School of Engineering, Polytechnic Institute of Porto, Porto, Portugal 
 
Abstract 
Cancer-related venous thromboembolism (VTE) worsens disease prognosis, leading to death in a 
vast majority of cases. A point-of-care identification of VTE for risk-assessment and treatment 
prescription could enhance the quality of life and survival of cancer patients. Thus, the 
development of biomedical devices for low-cost and rapid monitoring of VTE biomarkers is 
imperative.  
The versatility of biosensor approaches can answer the demand for more accurate and personalized 
portable devices. New nanotechnological-based strategies are particularly valuable concerning the 
detection of disease biomarkers in complex biological samples, like body fluids containing 
interfering molecules. Molecular imprinting is a cost-effective technique to obtain selective 
recognition of target biomarkers. The synthetic complementary recognition nanocavities in 
polymeric matrices show advantages over their biological counterparts, like improved stability and 
reusability. 
The new technology proposed in the STRIP2SENSE project is based on non-invasive test strips 
tailored with biomimetic plastic antibodies that assure the required specificity, sensitivity and 
accuracy in real-time analyses. It is expectable that the novel sensing strips compete with the 
standard methods and can have future translation into clinical practice. 
 
Acknowledgements. The authors gratefully acknowledge the financial support from 
STRIP2SENSE project (NORTE-01-0145-FEDER-024358-SAICT-POL/24358/2016). 
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Artificial antibodies based potentiometric sensors for 
monitoring diabetic ketoacidosis 
Pedro D.P. Martins1 *, Liliana A.A.N.A. Truta2,3, Rúben Fernandes1,3 and M. Goreti F. Sales2,3 
1School of Health, Polytechnic Institute of Porto, Portugal 
2BioMark, Sensor Research/ISEP, School of Engineering, Polytechnic Institute of Porto, Portugal  
3CEB-Biological Engineering Centre, Minho University, Portugal  
 
Abstract 
Diabetic ketoacidosis is a pathological condition characterized for the complex disordered 
metabolic state (as hyperglycemia, metabolic acidosis, dehydration or ketosis), caused by the total 
failing of insulin production for beta cells in the islets of Langerhans (type 1 diabetes) or 
abnormalities in the peripheral insulin action and insulin secretion (type 2 diabetes). This 
pathogenesis can be also associated with the increase of counter-regulation hormones, leading to 
an increase in the hepatic glucose synthesis and a decrease in the peripheral tissues, resulting in 
hyperglycemia and hyperosmolarity. The effect of lipolysis increase leads to an increase in the 
production of free fatty acids, which are oxidized in the hepatic microsomal system and converted 
to acetyl-CoA. When acetyl-CoA production exceeds hepatic utilization capacity, this substance 
acts as a substrate for the production of ketone bodies (β-hydroxybutyrate (BHB), acetoacetate and 
acetone), causing ketonemia and metabolic acidosis. 
The present work describes an original approach to create a potentiometric biomimetic sensor for 
BHB detection. For this purpose, a molecularly imprinted material, acting as an antibody, was 
obtained by bulk polymerization of acrylic acid, trimethylolpropane trimethacrylate and BHB. In 
parallel, a non-imprinted polymer material (NIP) was produced, following an equivalent 
procedure, without the target template. The chemical features of the obtained MIP materials were 
followed by Fourier Transform Infrared (FTIR) spectroscopy. The selective membranes were 
prepared by dispersing the sensing material in a plasticized PVC membrane, including or not a 
lipophilic ionic additive. These membranes were then casted on a solid conductive support made 
of graphite, placed at the smaller end of the plastic body of an insulin syringe. The analytical 
* Corresponding author, E-mail: pires_martins89@hotmail.com 
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performance of the devices showed sensitive readings of BHB in wide concentration range, up to 
0.01 mg/mL.  
Overall, the proposed biomimetic sensor offers a simple and low-cost approach for monitoring 
BHB in the diabetic ketoacidosis disease, being the application to real serum samples successful.  
Keywords  
Diabetic ketoacidosis, β-hydroxybutyrate, Molecularly imprinted polymers, Potentiometry. 
 
Acknowledgements. The authors gratefully acknowledge the financial support from BIO4DIA 
project (NORTE-01-0145-FEDER-024325–SAICT-POL/24325/2016). 
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Molecular imprinting technology for detecting biomarkers 
of venous thromboembolism 
Sara Resende*, Carla F. Pereira*, Manuela F. Frasco* and M. Goreti F. Sales 
BioMark-CEB/ISEP, School of Engineering, Polytechnic Institute of Porto, Porto, Portugal 
 
Abstract 
Innovative non-invasive sensing devices to be used in point-of-care are foreseen to benefit patients 
and simultaneously improve the management of healthcare resources. Coagulation processes are 
highly linked to cancer, and the increased risk of developing venous thromboembolism (VTE) is 
a clinical concern. Cancer patients with VTE have worse survival outcomes. Thus, it is crucial to 
have an early and accurate VTE diagnosis.  
Herein, a new technology is proposed to detect biomarkers of VTE, helping to solve the limitations 
of the current diagnostic techniques. The biosensor relies on high-affinity molecularly imprinted 
polymers (MIP), which guarantee selective and sensitive biomarker recognition. The sensing 
layers shall be assembled on test strips that hold the obvious advantage of providing a rapid and 
non-invasive access to urine biomarkers in single-use point-of-care. 
The MIP-based sensors were designed and synthesized as selective recognition elements of 
peptides of the coagulation cascade. The analytical performances enabled to obtain sensitive 
responses in the range of physiological relevant levels. Thus, the proposed straightforward 
approach envisions a rapid development of the aimed test strips. 
 
Acknowledgements. The authors gratefully acknowledge the financial support from 
STRIP2SENSE project (NORTE-01-0145-FEDER-024358-SAICT-POL/24358/2016). 
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BIO4DIA: Early detection and monitoring of metabolic 
progression of type 2 diabetes 
 
R. Fernandes 1, S. Reis 2, D. do Ô 3, C. Luís1, P. Martins 1,2, L. Truta 2, JM. Macedo 1,  
MGF. Sales 2, J. Raposo 3, AR. Andrade 3, P. Macedo 3, AC. Pereira 2, G. Martins 2,  
L. Carneiro 2, N. Ferreira 2, M. Frasco 2, S. Guerreiro 1, R. Ribeiro 3, P. Baylina 1 * 
1School of Health, Polytechnic Institute of Porto, Porto, Portugal 
2School of Engineering, Polytechnic Institute of Porto, Porto, Portugal 
3Portuguese Diabetes Association, Lisbon, Portugal 
 
Abstract  
According to the latest International Diabetes Federation 2015 report, the total health expenditure 
with type 2 diabetes (T2D) spent globally was of 673 billion USD in 2015 and it expected that this 
effort increases up to 802 billion in 2040. Additionally, patients experienced a series of 
complications, ranging from eye, cardiovascular, and kidney disease as well as pregnancy 
complications, nerve damage, foot infections and impaired regeneration [1-4]. Based on the most 
recent research in this area the cornerstone of treatment of T2D is the adoption of a healthy diet, 
increased physical activity and maintenance of a normal body weight and those are modifiable risk 
factors [5-9]. 
Actually, the large investment in T2D research allowed the identification of biomarkers that can 
be used to describe the progression of a sub-clinical stage to a clinical stage of diabetes and some 
biomarkers have been described with predictive potential value to differentiate between 
progressors/non-progressors [10-12]. 
Nevertheless, there is no technology at the present moment, that could be used at bed side and that 
could be rapidly and easily used by clinicians to monitoring their high-risk patients and also that 
could be sensitive, precise and cost effective. So, smaller, faster (one-step), and cheaper devices 
are highly desired for replacing the time-consuming and expensive laboratory-analytical methods. 
Biosensors meet these criteria. The idea behind the present proposal is to develop a point-of-care 
(POC) device for the measurement of biomarkers with predictive potential value to differentiate 
high risk individuals between progressors/non-progressors [13-17]. 
* Corresponding author, E-mail: pilarbaylina@ess.ipp.pt 
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This new perspective would benefit all the interested parties: Patients would benefit from better 
medical care in a personalized medicine perspective; Clinicians would benefit from a rapid, 
accurate, sensitive, low cost and easy-to-use tool for diagnosis and monitoring; Global health 
would benefit specially in those cases were early detection could reverse de course of the disease, 
decreasing the direct and indirect costs associated to that. 
The BIO4DIA research team has know-how in the field (ADPD the reference institution for 
Diabetes health care in Portugal, Biomark/P.PORTO a leading institution for biomarkers research 
and biosensor development) and the working conditions to develop a prototype of POC device to 
measure T2D biomarkers (Technology readiness levels at stage 3/4), with future Patent 
submission. 
To achieve these outcomes the project will take into account the following stages: 1) the reference 
values adjusted for the Portuguese population of the selected biomarkers must be clearly identified; 
2) The biorecognition element of the biosensor must be selected in a way that allows the high-
selective and accurate for the proper measurement of the selected biomarker; 3) The prototype 
should be submitted to a pre-test in a clinical environment.  
This project is being developed with the collaboration of academic institutions that have the 
opportunity to involve both researchers and students from different BSc, MSc and PhD 
backgrounds that are taught in house: BSc in Medical Biotechnology; Biomedical Engineering, 
Chemical Engineering, MSc in Computation and Medical Instrumentation, Chemical Engineering 
and Health Biochemistry and from the PhD in Biotechnology (col. with Vigo University/Spain). 
The clinical community of APDP have the opportunity to involve several health professionals such 
doctors from several specialities regarding Diabetes and their complications, nurses and health 
technicians.  
Finally, the BIO4DIA team is committed in prevention of T2D. Regarding this topic, it is intended 
to develop several workshops and health education programs. APDP has a School of Diabetes with 
programmes for both professional and general publics for diabetes education in Lisbon and Oporto. 
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Glycated Albumin: A new biomarker for monitoring 
metabolic progression of diabetes 
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Abstract  
One of the consequences of the metabolic progression of diabetes is kidney disease, being also a 
main cause of diabetes related morbidity and mortality. Therefore, earlier adoption of methods to 
estimate chronic kidney disease risks along with a more accurate glycemic index for patients with 
type 2 diabetes mellitus is highly desirable. 
One of the widely used tubular injury markers is N-acetyl-β-D-glucosaminidase (NAG), a 
lysosomal enzyme of renal proximal tubular epithelial cells. One study demonstrated that the 
association between glycated albumin (GA) and uNAG excretion and observed that GA was 
significantly associated with uNAG excretion independent of other confounding factors. 
Consequently, this study suggest that GA can be a strong independent predictor of early renal 
tubular damage, beyond its role as a surrogate marker of glucose control (Huh et al., 2018). 
The glucose and other sugars react spontaneously with free amino terminal residues of serum 
proteins, like albumin (the most abundant of serum protein). Glycated albumin (GA) levels 
increase in states of abnormally high glucose concentrations such as diabetes and can hence be 
used for assessing glucose control over a short to intermediate time frame (approximately 14-21 
days, half-life of serum proteins (Danese et al., 2015). 
Glycated albumin (GA) has been identified as a good biomarker because are not affected by 
changes in erythrocyte lifespan, measurement is not influenced by anemia or other conditions 
which invalidate HbA1c measurements (Wu et al., 2016). Several studies revealed the association 
of increased GA values with the presence of diabetic retinopathy, nephropathy, and cardiovascular 
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complications; these findings also support the use of GA measurements in the diagnosis of diabetes 
(Danese et al., 2015; Wu et al., 2016). 
Although further studies are needed to establish whether GA may complement (or even replace) 
conventional measures of glycemic status such as HbA1c, it is undeniable that GA is already 
helping the clinical management of patients with diabetes in whom HbA1C values are unreliable 
(Danese et al., 2015). 
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Abstract  
Diabetes Mellitus is a metabolic disorder that is growing at epidemic proportions worldwide and 
is consensually classified in type 1 Diabetes, type 2 Diabetes and Gestational Diabetes (1). One of 
the most common complication of diabetes is the lower extremity is the diabetic foot ulcer (DFU). 
Diabetes is also the most common cause of lower extremity amputation (LEA). Several foot 
disorders, such as foot ulcerations and infections are a major source of morbidity and a leading 
cause of hospitalization for persons with diabetes. Thus, ulceration, infection, gangrene, and limb 
amputation are major complications of the disease, estimated to cost billions of dollars each year 
and have attracted the attention of health policy providers (2, 3).  
The most common single precursor to lower extremity amputations among person with diabetes is 
the foot ulceration and the treatment of the infected foot wound represents one quarter of diabetic 
hospital admissions. The risk calculation and prediction LEA rely on stratified systems to be 
applied in the clinical practice. The several clinical valuable systems used to stratify subjects with 
DFU by risk of consequent LEA present overall substantial accuracy values. However, authors 
consider better for implementation in daily clinical care those that use fewer easy to use dichotomic 
variables (4,5).  
Decision-making tools for the management of lower extremity infections are typically depend on 
inflammatory markers. Such markers rely basically on the white blood cell count, erythrocyte 
sedimentation rate, and C-reactive protein which are used to earlier assess DFU patients and/or to 
monitor the progression of medical or surgical therapy. Initially, procalcitonin was used to monitor 
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antibiotic therapy patients in the intensive care setting but now procalcitonin as being revealed 
useful as a new inflammatory marker that is specific for an infectious course (5,6). 
In the present project we pretend to evaluate the predicting value of procalcitonin as biochemical 
marker for the prediction of risk of amputation and study its significance as an additional parameter 
for a clinical estimation tool regarding risk assessment.   
Keywords 
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Abstract  
According to the International Diabetes Federation, Diabetes mellitus type 2 (DM2) has affected 
more than 425 million people in 2017 worldwide [1]. Not only is it a disease responsible for more 
than 4 million deaths, but also a trigger for other non communicable diseases and a huge burden 
on national health systems. 
The most important clinical manifestation of T2DM is hyperglycemia and monitoring of blood 
glucose levels remains the only method of screening. However, when glucose levels are high, the 
disease is already in place. The large investment in DM2 research allowed the identification of 
biomarkers that could be used to describe the progression of diabetes and some were described as 
having a predictive potential value to differentiate between progressors / non-progressors. One of 
the biomarkers described is Galectin-3 (Gal3). Previous studies of our group have already 
demonstrated a correlation of Gal3 between diabetic and non-diabetic animals [2]. 
Gal3 has multiple functions depending, among other factors, on its location and target tissue. 
Intracellular Gal3 acts as a pre-mRNA splicing factor and regulates the cell cycle through the 
modulation of cell proliferation, death and differentiation. In addition, it promotes cell proliferation 
and cell survival, protecting against induced apoptosis. Extracellular gal3 further regulates cell 
adhesion. Gal3 is capable of binding high affinity, internalization and degradation of advanced 
glycation products, playing an important role in diabetes and aging [3]. 
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Pugliesi et al. demonstrated that in diabetic cohorts, plasma levels of Gal3 were correlated with 
the prevalence of diabetes and related metabolic conditions. Galectin-3 is considered not only as a 
marker of heart failure but also as a mediator of the disease due to its pro-fibrotic action [4]. 
The aim of the present study is to evaluate the reference values for non-diabetic, pre-diabetic and 
human diabetic individuals of the Portuguese population. 
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Abstract  
The epidemic of type 2 diabetes (T2D) continues to soar worldwide. Driven by changes in human 
habits, from availability of energy dense processed foods to the decrease of physical activity, T2D 
constitutes already a heavy burden of disease and a worrisome barrier for the sustainability of 
National Health Systems. Indeed, it affects 415 million people (8.8% prevalence), was responsible 
for 5.0 million deaths in 2015, and is estimated to cost 1/9 of all Health expenses (1).  
Within Europe, Portugal is reported as having the highest prevalence of diabetes: an estimated 
9.6% by World Standard Population (2). But if we take into consideration the age distribution of 
the Portuguese population, then estimates increase to 12.9%. This means that 1 million Portuguese 
have diabetes, with almost half of these still undiagnosed. Additionally, 2 million (a third of the 
adult population) are estimated to have intermediate hyperglycemia (or prediabetes), being largely 
unaware of this condition (3).  
Since it was clearly shown that a life style modification program was able to prevent, over 3 years, 
more than half the expected new cases of diabetes (4), many clinical trials have provided evidence 
on the beneficial effect of interventions targeting individuals at high-risk and focused on nutrition 
and exercise (5). These in turn have supported the proposal of guidelines for diabetes prevention 
(6,7). Nonetheless, the main challenge remains to effectively translate these clinical trials and 
guidelines to widespread lifestyle interventions (7).  
Portugal is in dear need of a strategy based on prevention for managing the diabetes crisis. That 
was recently highlighted in ‘A Future for Health’, a report commissioned by the Calouste 
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Gulbenkian Foundation, where Diabetes Prevention was elected one of three main challenges to 
preserve SNS sustainability (8). 
Regarding diabetes risk assessment, a large number of tools have been proposed to detect people 
at high- risk to develop diabetes and/or already within prediabetes (9-11). Several are based on 
questionnaires of parameters obtained noninvasively (12), and, among those, the Finnish T2D Risk 
Score (FINDRISC) has been validated and used as a screening tool for diabetes prevention 
programs (13-15). The FINDRISC 8 item questionnaire structure enables it to be applied in 
primary care, field screening initiatives, or even by individuals themselves. In Portugal, it has been 
used by us in the national diabetes prevalence study (PREVADIAB) (16). A supplemental strategy 
is to identify high-risk by screening existing Electronic Health Records (17). 
In this work we propose to compare four risk assessment tools in their easiness of application and 
reliability, thus allowing stratification the risk of metabolic progression of the disease. 
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Abstract 
Objective: It has been described that fructosamine is directly proportional to glycated 
haemoglobin (HbA1c), and that their correlation can be expressed by the equation 
Fructosamine=(HbA1c-1,61)*58,82. Since it has been proposed that serum proteins, other than 
haemoglobin, when exposed to glycation may be directly related to a further decrease in insulin 
sensitivity, we investigated, in a general Portuguese population, if glycation levels as measured 
through HbA1c can be confidently extrapolated to express total protein glycation.  
Results: HbA1c and Fructosamine measurements showed weak correlation (r2=0,2584) in the 
studied population. Additionally, it was observed that this drift is independent of the classification 
of glucose metabolism provided both by fasting glycemia and 2h post-OGTT. Paradoxically, when 
the variation between measured and theoretical (estimated through HbA1c) Fructosamine was 
analysed by Fructosamine quartiles, it was observed that while for the first quartile there was a 
good correlation between HbA1c and total protein glycation, this is gradually lost until the last 
quartile, where  extrapolation based on HbA1c underestimates the real measure of serum total 
protein glycation in about 30% (p<0,001). 
Conclusion: HbA1c constitutes an inadequate surrogate for assessing serum total protein 
glycation, at least in the general population studied. Thus, to study the glycation of other serum 
proteins other than haemoglobin should be use specific quantification tests to determine glycation 
levels in those proteins.   
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Abstract 
One of the objectives of the FishBioSensing project is the development of an electrochemical 
biosensor for the determination of the safety and quality of fishery products to address the current 
fish industry demands. Electrochemical biosensors are good alternatives to conventional methods 
since they provide fast and simple detection without the need of specialized workers, complicated 
sample treatment procedures and expensive equipment. The chosen analyte in this work was 
histamine, which is an important fish freshness indicator; inappropriate storage conditions after 
fishing increases its levels. Furthermore, the consumption of products with a high concentration 
of histamine can cause food poisoning, so its maximum concentration is legally regulated. 
Histamine was analysed in fish samples by using a simple, miniaturized and low-cost enzymatic 
sensor based on a screen-printed electrode. The sensor was constructed by immobilizing an 
enzyme (diamine oxidase) on the surface of the electrode and histamine was quantified through 
the use of a redox mediator to record the analytical (amperometric) signal. 
The sensor showed a selective response towards histamine and provided accurate and precise 
results and a limit of detection that meets the needs of the fishing industry. Moreover, it’s response 
maintained stable for over a month after construction. Therefore, the developed sensor could be 
useful in routine analysis. 
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Abstract  
Residues are an endogenous and renewable energy source, which valorisation is imperative.  The 
national energy strategy in 2020 made a commitment to renewable energies, providing strategies 
to improve the use of the energetic potential of waste recovery. The growth of biodiesel industry 
in Portugal has generated large amounts of crude glycerol. The current solution is the sale of this 
contaminated by-product which is no longer an economically interesting option. On the other hand, 
the resulting animal fat from leather industry has special characteristics, which determine its 
application and management. So, there is a real concern related to the management of those by-
products. This project aims to evaluate the technical viability of crude glycerol gasification and 
glycerol/fat mixtures co-gasification. Crude glycerol was pre-treated using an ion exchange 
process, in order to reduce its salt content. The gasification process was studied in a fixed bed 
reactor using steam as gasification agent. The effect of temperature, oxidant agent and glycerol/fat 
ratio on the producer gas composition were analysed. The results revealed that the gasification of 
treated glycerol and the co-gasification of glycerol/fat mixtures appear to be feasible options for 
the valorization of these by-products. Best result of gasification parameters were obtained at the 
highest tested temperature (950ºC). The results showed that the increase of the water content in 
the feed mixture lead to higher values of H2 in the producer gas. The parameters that assess the 
gasification performance revealed very good results, similar, in magnitude, to the ones obtained 
for technical glycerol gasification. 
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Abstract  
Marine oil spills have a large economic and ecologic impact in the ecosystem of marine life. 
Incidents with oil spills occur with some regularity during the exploration, production, and 
transport of petroleum products[1]. In the last nine years, between 2010 and 2018, were registered 
59 spills with 7 tonnes or more, resulting in a total of 163.000 tonnes of oil spills in the 
environment, with 92% of this amount was spilled in 10 incidents[2]. The occurrence of such 
incidents requires immediate, simple, effective and eco-friendly actions to minimize 
environmental damages. First-line responses typically include physical (e.g., controlled burning; 
absorbing) and chemical (e.g., dispersing) removal of oil, which is largely constrained by maritime 
conditions. Though these treatments are important to rapidly control the diffusion and drift of the 
oil, they are not suitable for ecological restoration. The use of microorganisms with a natural 
capacity to degrade petroleum is highly advantageous in an environmentally friendly process and 
allows complete decomposition of complex petroleum hydrocarbons[3]. The success of 
bioremediation, to improve petroleum removal and reduce clean-up time and cost, relies in two 
major approaches: (i) addition of nutrients to stimulate the growth of the microorganisms that 
break down oil (Biostimulation) and (ii) the addition of pre-grown microbial cultures/consortia to 
enhance microbial populations (Bioaugmentation). This mitigation strategy usually involves the 
introduction of non-native microorganisms in the affected environment. The ROSM (Robotic Oil 
Spill Mitigation) project proposes to address the development of autonomous and coordinated 
actions able to increase the efficiency of the bioremediation process, by deploying microorganisms 
and nutrients in oil spill detected areas with a team of heterogeneous robots. The proposed 
approach will be based on the production of native microbial consortia with bioremediation 
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capacity, and the adaptation to autonomous vehicles for in-situ release of autochthonous 
microorganisms (bioaugmentation) and nutrients (biostimulation), and their use combined with 
heterogeneous robots, autonomous surface vehcile (ASV) ROAZ and unmanned aerial vehicle 
(UAV) STORK, with different levels of intervention[4], will result in a more cost-effective 
manner, without risking human lives. Preliminary field tests have been performed in Leixões 
Harbour in Porto, Portugal, with an oil spill created inside Gazebo simulator scenario, projected 
on a known position from the real world. Both vehicles were able to coordinate the oil spill 
mitigation task with the ASV ROAZ being able to contour the oil spill while is deploying 
microorganisms and nutrients (bioremediation) capable of mitigate and contain the oil spill spread, 
and the second one for an UAV responsible for performing the coverage of the entire spillage area 
with the same microorganisms and nutrients deployment capabilities. 
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Abstract  
Over the last few years, oil spill incidents occur with some regularity during the exploration, 
production and transport of the petroleum products, causing a large economic and ecologic impact 
in the world community, with high losses in the marine ecosystems[1, 2]. In 2018, the total volume 
of oil lost to the environment recorded was approximately 116,000 tonnes[3], causing huge 
impacts into the ecosystems. Beside this, current oil spill cleaning technologies aren’t suitable for 
ecological restoration neither fast enough to start the mitigation process, since this operation 
requires several surface and aerial vehicles. To minimize these impacts and reduce the time 
response of the initial mitigation process, autonomous vehicles, such as UAVs and ASVs, can be 
used to perform oil spill monitoring and mitigation tasks[4]. With this thought, ROSM and Spilless 
projects emerged, aiming the development of an autonomous and coordinated system between two 
vehicles, UAV and ASV, in order to increase the efficiency of the mitigation process using 
bioremediation techniques[5].  This paper presents the design and implementation of the multirotor 
UAV developed for both projects, capable of identifying, locating and mitigating the oil spill, by 
using a release system of consortia with bacteria and nutrients. In this way, all mechanical and 
electronic aspects were developed, resulting in a new hexacopter platform with a novel design. 
The vehicle is composed by a set of visible and infra-red cameras, a LiDAR sensor, an autopilot, 
a high precision IMU and GNSS, a high power on-board computer, used for processing all the data 
and perform an autonomous control, and a bacterial spreading system, presenting an overall 
payload of 45 kg. Several flight tests were carried out, in indoor and outdoor environments, 
allowing to adjust the control parameters of the UAV and the release system behavior in the 
presence of different conditions of operation. The preliminary tests of the projects occurred in the 
Leixões Harbour in Porto, Portugal, where the oil spill was implemented in a simulated 
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environment, resulting in a cooperative and simultaneous maneuver between the UAV and the 
ASV. 
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Abstract  
The paramount importance of obstacle avoidance in a path-planning function, for an autonomous 
mobile robot, its a well stated fact. In a two-dimensional scenario, that contains obstacles with an 
arbitrary shape/contour and well-defined and continuous boundaries, the vehicle should be capable 
of defining a trajectory from its initial position to the goal position, while maintaining a safety 
distance from the boundaries of the obstacles present in its path, to avoid a collision with said 
obstacles. This work presents a comparison study between Obstacle Avoidance algorithms using 
Potential Functions and using Local Path Planning, more specifically between two approaches 
presented in [1] and in [2]. This comparison and following presentation of comparative results are 
part of an INESC TEC study of algorithms to be applied, under the national research project ROSM 
(Robotic Oil Spill Mitigation). This project aims to develop new and viable solutions to tackle 
maritime pollution, in particular oil spills, through the production of native organisms, with 
bioremediation capacity, and the adaptation of unmanned and autonomous vehicles for the 
application of such bioremediation treatments. By doing so, these systems can be used as first line 
responders to pollution incidents in a fast, efficient and low cost way. 
The specific scenario for the application of this obstacle avoidance algorithm is an ocean surface 
with an Autonomous Surface Vehicle (ASV), ROAZ [3], that has an aerial perspective of the scene. 
The oil spillage represents one or multiple obstacles in two dimensions while the vehicle knows 
its position provided through its sensors, GPS and IMU and knows the obstacles positions through 
the aerial perspective provided by an auxiliary Unmanned Aerial Vehicle (UAV). The vehicle 
should be able to contour the oil spill completely, while maintaining its orientation face to the 
closest obstacle contour point, to have its sprinkler facing the spillage and release the spillage 
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containing chemicals. The results will detail the evaluation of several methods[2][1] able to ensure 
a robustness and efficient approach for oil spill mitigation with an ASV.  
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Abstract  
The aim of the project TheRoute is to generate automatic routes for tourists and visitors to points 
of interest related to Tourism, Heritage, Arts and Culture. The Platform developed in Porto creates 
customized tourist routes in the North region of Portugal. The suggested routes are appropriate to 
the profile of the tourist and groups of tourists. The project also considers aspects related to 
mobility (transportation), health, well-being and accessibility. The system is accessible by 
computer, tablet and smart phone environment, covering the life cycle of the tourist experience. 
TheRoute has been developed considering the notion of Ambient Intelligence (AmI) and Context 
Awareness. This paper focuses on the proposed Architecture, highlights the interface of the mobile 
platform, the Modelling process of Points of Interest and the Thematic Tourist Tours. 
Results and conclusions 
The development of TheRoute was driven by a multidisciplinary collaboration between three 
Higher Education Institutions (P.Porto, ISEP, through the GECAD R & D group and the 
Polytechnic Institute of Viana do Castelo) and one Enterprise (Douro Azul), based on an extensive 
literature review about mobile applications for tourism. This process was also a user (Tourist) 
participatory design approach which advocates a change of perspective: instead of design for users, 
it is projected to design with users. 
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The mission of theRoute was to make an easy and automatic recommender system for tourist to 
visit the North region of Portugal. Also, the platform can promote the marketing of the Regional 
Tourism and Monitoring Information in an Intelligent way. TheRoute Systemic capable of 
understating the tourist information and convert it as a targeted suggestion for his/her experience. 
We designed one multidisciplinary Ambient Intelligent system for getting appropriate information, 
based on tourist profile, psychology, available Point of Interests and also with related information.  
Additionally, with the use of the system and its statistics, it will be possible to analyse the profile 
of the tourist (or group of tourists) of an area, identifying touristic necessities in order to improve 
the design of touristic-related offers.  
Also, the solution to presents several thematic tours route to the end user can, in the long run, 
allowing an approach to different Heritage typologies, by identifying potential 
objects/motifs/elements of interest (POIs) of the North region of Portugal. 
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Abstract  
LED-based technology is transforming public lighting networks, favoring smart city innovations. 
Beyond energy efficiency benefits, LED-based luminaries provide real time stateful data. While 
most of the municipalities manage all their luminaries equally, independently of its state or the 
environmental conditions, we aim to go beyond basic consumption monitoring and dimming 
control: we combine the individual luminaries’ state data with data about the environment (e.g. 
temperature, humidity) to model, at an individual level, power consumption and working 
temperature. These two variables are of utmost importance for two major challenges addressed by 
this project: power consumption and preventive maintenance. We thus built two different models 
(distributed random forest) for predicting power consumption and working temperature. These 
models evidenced two relevant aspects: 1) the operation of the luminaries is significantly 
influenced by external factors (namely environmental ones); and 2) there are operational variations 
between luminaries, that is, each one operates at a different temperature and consumes power 
differently. The main contribution of this work is to model these aspects, that must be considered 
when developing more precise energy consumption predictions or defining preventive 
maintenance plans. 
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Abstract  
Smart lighting networks are gaining relevance in modern cities as traditional systems are replaced 
by LED ones. In their management, maintenance is one of the central tasks. Maintenance plans 
can be implemented in two ways: preventively (by continuously monitoring and predicting failure) 
or reactively (by acting upon failure). We propose an approach for preventive maintenance that 
relies on the combination of two complementary models of the network, that classify the state of 
each luminary as normal or abnormal: one is based on rules defined by a Human expert, the other 
is based on a statistical analysis of the data. Both models have an accuracy of >0.99, showing that 
it is possible to accurately distinguish between normal and abnormal states. Moreover, both models 
have a high degree of concordance in their predictions. Based on both models, a classification 
service was developed that can be used in real-time to detect luminaries that are working 
abnormally. This service is the basis of a Decision-Support System that helps human experts 
identify luminaries that operate abnormally and are thus more likely to fail, improving the 
efficiency and efficacy of preventive maintenance plans. 
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Abstract  
In CONTEST project, business models and market structures for intensive and efficient use of 
distributed energy resources in local energy communities, considering the interaction with current 
and future wholesale markets have been explored. Aggregation of consumers and of energy 
resources have been addressed as enablers for the participation in local transactions, and in 
wholesale markets. Demand response and the active contribution of consumers are incentivized, 
namely through innovative adequate tariff and remuneration. A hybrid simulation platform 
combining multi-agent technology with physical emulation was improved, enabling the realistic 
test and validation of the results. 
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Results 
The results obtained cover the following aspects: 
• Business models to support the implementation of a fully transactive energy system, 
through the integration of local electricity markets in the current market structure. 
• Innovative aggregation methods using Artificial Intelligence and data mining techniques. 
• Definition of advanced dynamic energy tariffs and remuneration schemes, which will 
transmit the local and wholesale market value to the small players. 
• Validation of the developed business models and methods in a laboratorial prototype, 
through the integration in a simulation platform existing in ISEP.  
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Abstract 
Positional plagiocephaly is a condition characterized by an asymmetrical distortion of the cranium. 
A baby’s skull is not strong, so it can suffer deformations, which cause plagiocephaly. In severe 
deformations, to fix the problem, the baby may need to use an orthosis, that should be used when the 
baby has between 3 and 18 months of age [1]. 
The orthosis will allow the head to grow gently back into a normal shape. This treatment must be 
done early, before the fontanels close and the cranium fuses together. 
The SmartOrthosis project aimed to automatize the process of orthosis’ creation for the treatment of 
positional plagiocephaly. The development of SmartOrthosis was driven by a collaboration between 
ISEP (from P. Porto), though the LAMU (Multimedia Lab) team and IPCA, though 2AI. 
In order to reach the aforementioned objective, the development was divided into three phases:  
• automatic anthropometric analysis,  
• automatic cranial orthosis’ design and  
• cranial orthosis’ prototyping. 
In the phase of the automatic anthropometric analysis, it was developed methods to treat the point 
clouds in order to obtain the necessary measurements and points. The automatic cranial orthosis’ 
design will develop processes to create the 3D model of the cranial orthosis, using the measurements 
obtained previously.  
The prototype of the orthosis will be made using the previously obtained models and it will be studied 
materials and sensors necessary for a correct functioning of the orthosis. In order to make the results 
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usable for doctors and other medical professionals, a solution with a graphical interface has been 
developed by ISEP team.  
The solution was implemented using Unity, C# and R. The Unity was chosen by its capabilities in 
building interfaces that conjugate 2D and 3D elements and because Unity allows to see the results 
more easily and fast while the solution is developed. The R language was chosen because of the 
diversity of processing algorithms already developed in this language. 
The graphical interface of the developed solution has two main areas. The first area is dedicated in 
the visualization and manipulation of point cloud. The second area is dedicated to view the results 
and make the necessary operations. In the Measures functionality, it’s shown at left top corner the 
top view of the head. The top view of the head allows the user to see where the width and length was 
measured and it also allows the user to see easily and more clearly the shape of the head. 
 
The objectives of the first phase were achieved, with the development of the application with 
graphical interface able to treat and analyse the clouds of points, in order to obtain the points and 
reference measures. 
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